These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A survey of generic drug legislation and geriatric pharmacotherapy: opinions of those who generate the literature. Morgan JP; Schwartz LL; Sherman FT J Am Geriatr Soc; 1983 Sep; 31(9):535-9. PubMed ID: 6886279 [TBL] [Abstract][Full Text] [Related]
23. Framework and development of a comprehensive drug product coding system. DeVito CA; Aldridge GW; Wilson A; Vidis JS; Goldberg T; Dickson WM; Moore WE Contemp Pharm Pract; 1979; 2(2):62-5. PubMed ID: 10316818 [No Abstract] [Full Text] [Related]
24. Where the profession is goint with drug product selection. Eggleston MW J Am Pharm Assoc; 1973 Jan; 13(1):32-3. PubMed ID: 4682575 [No Abstract] [Full Text] [Related]
25. Information flows on a drug product selection bill. Smith MC Am J Pharm Sci Support Public Health; 1978; 150(2):51-8. PubMed ID: 686161 [No Abstract] [Full Text] [Related]
26. FDA drug list: key to generic substitution. FDA Consum; 1979 Feb; 13(1):15-7. PubMed ID: 10308816 [TBL] [Abstract][Full Text] [Related]
27. [European legislation on biological similarity recommendations of the European Agency on Medications concerning drug quality]. Prugnaud JL Nephrol Ther; 2009 Feb; 5 Spec No1():3-5. PubMed ID: 19233075 [No Abstract] [Full Text] [Related]
28. Drug product selection in Florida--all it could be? Welsh JS Am Pharm; 1979 Sep; 19(10):12-3. PubMed ID: 539530 [No Abstract] [Full Text] [Related]
29. Generic drug purchasing. Mehl B Hosp Pharm; 1988 Feb; 23(2):162-4 contd. PubMed ID: 10286432 [No Abstract] [Full Text] [Related]
30. In U.S., biosimilars still await FDA decision. Finkelstein JB J Natl Cancer Inst; 2006 Apr; 98(7):435. PubMed ID: 16595775 [No Abstract] [Full Text] [Related]
31. The pharmacist's role in the nonsteroidal anti-inflammatory drug selection process. Barkin RL Am J Ther; 2008; 15 Suppl 10():S17-9. PubMed ID: 19127124 [TBL] [Abstract][Full Text] [Related]
32. Therapeutic drug substitution. Artherholt WG Iowa Med; 1988 Oct; 78(10):485-6. PubMed ID: 3182226 [No Abstract] [Full Text] [Related]
33. [European legislation on the development of biological similarity: recommendations on the European Agency on Medications with regard to efficacy and safety]. London G Nephrol Ther; 2009 Feb; 5 Spec No1():6-9. PubMed ID: 19233076 [No Abstract] [Full Text] [Related]
35. Brand name vs generic: the drug wars rage on. Manners S Can Doct; 1984 Dec; 50(12):32-5. PubMed ID: 10269303 [No Abstract] [Full Text] [Related]
36. [Government and drug provision]. Ariƫns EJ Ned Tijdschr Geneeskd; 1969 Oct; 113(41):1774-8. PubMed ID: 5344632 [No Abstract] [Full Text] [Related]
37. A pilot study on generic medicine substitution practices among community pharmacists in the State of Penang, Malaysia. Ping CC; Bahari MB; Hassali MA Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):82-9. PubMed ID: 17879323 [TBL] [Abstract][Full Text] [Related]
38. Substitution: expectations and realization. Gorrell JM Med Mark Media; 1981 May; 16(5):52, 54-7. PubMed ID: 10251529 [No Abstract] [Full Text] [Related]
39. Drug selection concerns more than rhetoric. McGregor T Am Pharm; 1988 Mar; NS28(3):6. PubMed ID: 3369347 [No Abstract] [Full Text] [Related]